Insider Transactions in Q3 2024 at Monte Rosa Therapeutics, Inc. (GLUE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
1,132,566
-18.17%
|
$6,795,396
$6.53 P/Share
|
|
Sep 13
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
9,269
-0.15%
|
$55,614
$6.16 P/Share
|
|
Sep 12
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
16,047
-0.26%
|
$96,282
$6.0 P/Share
|
|
Sep 11
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
541,897
-7.97%
|
$3,251,382
$6.0 P/Share
|
|
Jul 05
2024
|
Edmund Dunn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,610
-10.35%
|
$4,830
$3.83 P/Share
|